BIOMAT Database Logo BIOMAT Database Logo

Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia. 2004

Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
Department of Clinical Cell Biology, Chiba University Graduate School of Medicine, Chiba, Japan. ichiro-tatsuno@faculty.chiba-u.jp

OBJECTIVE Vasopressin (AVP) is reported to be an important factor for regulating cortisol secretion in patients with Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia (AIMAH). Recently, there have been several case reports of subclinical Cushing's syndrome due to AIMAH, in which the pathophysiological role of AVP has been unknown. The aim was to conduct an extensive investigation of AVP in the autonomous secretion of cortisol in subclinical Cushing's syndrome due to AIMAH. METHODS Five cases of AIMAH with subclinical Cushing's syndrome underwent prospective study including physical examination, imaging (MRI, CT and 131I-adosterol scintigraphy) and endocrinological evaluation that comprised basal plasma cortisol levels and urinary excretions of steroid metabolites, a dexamethasone suppression test and an AVP stimulation test. In case 1, left adrenalectomy was performed and the pathological diagnosis of AIMAH was established. An in vitro experiment using the cultured AIMAH adrenal cells was conducted to investigate cortisol secretion and expression of the V1-AVP receptor, mRNA by RT-PCR. RESULTS All five cases were discovered incidentally to have bilateral adrenal nodules. Imaging by MRI and CT revealed large multinodular lesions in both adrenal glands, which showed positive uptake on 131I-adosterol scintigraphy. Although the basal values of plasma cortisol and urinary excretions of steroid metabolites were within normal limits, autonomous secretion of cortisol was assumed to occur because of lack of suppression during dexamethasone suppression. The five patients had no overt signs of Cushing's syndrome, and they were therefore diagnosed with subclinical Cushing's syndrome due to AIMAH. In all five patients, AVP stimulated cortisol secretion in vivo, whereas desmopressin acetate failed to affect cortisol secretion. In case 1, AVP stimulated cortisol secretion from cultured AIMAH adrenal cells, but this secretion had no relationship with cAMP production. In addition, over-expression of V1-AVP receptor mRNA in AIMAH tissue was determined by RT-PCR. CONCLUSIONS Patients with subclinical Cushing's syndrome due to AIMAH commonly exhibit cortisol responsiveness to AVP, and this is probably mediated through activation of overexpressed V1-AVP receptors.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid

Related Publications

Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia.
May 1997, Journal of endocrinological investigation,
Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
[Cushing's syndrome due to huge bilateral adrenocortical multinodular hyperplasia--ACTH-independent bilateral adrenocortical macronodular hyperplasia(AIMAH)].
January 1994, Nihon Naibunpi Gakkai zasshi,
Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
ACTH-independent bilateral macronodular adrenocortical hyperplasia caused Cushing's syndrome.
January 1997, Urologia internationalis,
Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
Laparoscopic bilateral adrenalectomy for Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
January 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
[ACTH-independent macronodular adrenal hyperplasia and subclinical Cushing's syndrome].
February 2012, Medicina clinica,
Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
Cushing's syndrome due to a large adrenocortical adenoma with histological features simulating ACTH-independent macronodular adrenocortical hyperplasia.
April 2004, Pathology international,
Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
Cushing's syndrome secondary to ACTH-independent macronodular adrenal hyperplasia.
November 2007, Arquivos brasileiros de endocrinologia e metabologia,
Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
[ACTH-independent Cushing's syndrome secondary to macronodular adrenal hyperplasia].
April 2010, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion,
Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia.
January 2003, Chirurgia italiana,
Ichiro Tatsuno, and Daigaku Uchida, and Tomoaki Tanaka, and Hisashi Koide, and Azusa Shigeta, and Tomohiko Ichikawa, and Hironobu Sasano, and Yasushi Saito
Improvement of hypercortisolism by β-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia.
December 2009, Endocrine,
Copied contents to your clipboard!